Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2010

01-02-2010 | Original Article

Erectile Dysfunction Drug Receipt, Risky Sexual Behavior and Sexually Transmitted Diseases in HIV-infected and HIV-uninfected Men

Authors: Robert L. Cook, MD, MPH, Kathleen A. McGinnis, MS, Jeffrey H. Samet, MD, David A. Fiellin, MD, Maria C. Rodriquez-Barradas, MD, Kevin L. Kraemer, MD, MSc, Cynthia L. Gibert, MD, MSc, R. Scott Braithwaite, MD, MSc, FACP, Joseph L. Goulet, PhD, MS, Kristin Mattocks, PhD, MPH, Stephen Crystal, PhD, Adam J. Gordon, MD, MPH, Krisann K. Oursler, MD, ScM, Amy C. Justice, MD, PhD

Published in: Journal of General Internal Medicine | Issue 2/2010

Login to get access

Abstract

BACKGROUND

Health care providers may be concerned that prescribing erectile dysfunction drugs (EDD) will contribute to risky sexual behavior.

OBJECTIVES

To identify characteristics of men who received EDD prescriptions, determine whether EDD receipt is associated with risky sexual behavior and sexually transmitted diseases (STDs), and determine whether these relationships vary for certain sub-groups.

DESIGN

Cross-sectional study.

PARTICIPANTS

Two thousand seven hundred and eighty-seven sexually-active, HIV-infected and HIV-uninfected men recruited from eight Veterans Health Affairs outpatient clinics. Data were obtained from participant surveys, electronic medical records, and administrative pharmacy data.

MEASURES

EDD receipt was defined as two or more prescriptions for an EDD, risky sex as having unprotected sex with a partner of serodiscordant or unknown HIV status, and STDs, according to self-report.

RESULTS

Overall, 28% of men received EDD in the previous year. Eleven percent of men reported unprotected sex with a serodiscordant/unknown partner in the past year (HIV-infected 15%, HIV-uninfected 6%, P < 0.001). Compared to men who did not receive EDD, men who received EDD were equally likely to report risky sexual behavior (11% vs. 10%, p = 0.9) and STDs (7% vs 7%, p = 0.7). In multivariate analyses, EDD receipt was not significantly associated with risky sexual behavior or STDs in the entire sample or in subgroups of substance users or men who had sex with men.

CONCLUSION

EDD receipt was common but not associated with risky sexual behavior or STDs in this sample of HIV-infected and uninfected men. However, risky sexual behaviors persist in a minority of HIV-infected men, indicating ongoing need for prevention interventions.
Literature
2.
go back to reference Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357(8):762–74.CrossRefPubMed Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357(8):762–74.CrossRefPubMed
3.
go back to reference Smith KJ, Roberts MS. The cost-effectiveness of sildenafil. Ann Intern Med. 2000;132(12):933–7.PubMed Smith KJ, Roberts MS. The cost-effectiveness of sildenafil. Ann Intern Med. 2000;132(12):933–7.PubMed
4.
go back to reference Spindler HH, Scheer S, Chen SY, et al. Viagra, methamphetamine, and HIV risk: results from a probability sample of MSM, San Francisco. Sex Transm Dis. 2007;34(8):586–91.PubMed Spindler HH, Scheer S, Chen SY, et al. Viagra, methamphetamine, and HIV risk: results from a probability sample of MSM, San Francisco. Sex Transm Dis. 2007;34(8):586–91.PubMed
5.
go back to reference Swearingen SG, Klausner JD. Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am J Med. 2005;118(6):571–7.CrossRefPubMed Swearingen SG, Klausner JD. Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am J Med. 2005;118(6):571–7.CrossRefPubMed
6.
go back to reference Crosby R, Diclemente RJ. Use of recreational Viagra among men having sex with men. Sex Transm Infect. 2004;80(6):466–8.CrossRefPubMed Crosby R, Diclemente RJ. Use of recreational Viagra among men having sex with men. Sex Transm Infect. 2004;80(6):466–8.CrossRefPubMed
7.
go back to reference Paul JP, Pollack L, Osmond D, Catania JA. Viagra (sildenafil) use in a population-based sample of U.S. men who have sex with men. Sex Transm Dis. 2005;32(9):531–3.CrossRefPubMed Paul JP, Pollack L, Osmond D, Catania JA. Viagra (sildenafil) use in a population-based sample of U.S. men who have sex with men. Sex Transm Dis. 2005;32(9):531–3.CrossRefPubMed
8.
go back to reference Mansergh G, Shouse RL, Marks G, et al. Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect. 2006;82(2):131–4.CrossRefPubMed Mansergh G, Shouse RL, Marks G, et al. Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect. 2006;82(2):131–4.CrossRefPubMed
9.
go back to reference Marks G, Richardson JL, Milam J, Bolan R, Stoyanoff S, McCutchan A. Use of erectile dysfunction medication and unsafe sex among HIV+ men who have sex with men in care. Int J STD AIDS. 2005;16(3):271–2.CrossRefPubMed Marks G, Richardson JL, Milam J, Bolan R, Stoyanoff S, McCutchan A. Use of erectile dysfunction medication and unsafe sex among HIV+ men who have sex with men in care. Int J STD AIDS. 2005;16(3):271–2.CrossRefPubMed
10.
go back to reference Pantalone DW, Bimbi DS, Parsons JT. Motivations for the recreational use of erectile enhancing medications in urban gay and bisexual men. Sex Transm Infect. 2008;84(6):458–62.CrossRefPubMed Pantalone DW, Bimbi DS, Parsons JT. Motivations for the recreational use of erectile enhancing medications in urban gay and bisexual men. Sex Transm Infect. 2008;84(6):458–62.CrossRefPubMed
11.
go back to reference Horvath KJ, Calsyn DA, Terry C, Cotton A. Erectile dysfunction medication use among men seeking substance abuse treatment. J Addict Dis. 2007;26(4):7–13.CrossRefPubMed Horvath KJ, Calsyn DA, Terry C, Cotton A. Erectile dysfunction medication use among men seeking substance abuse treatment. J Addict Dis. 2007;26(4):7–13.CrossRefPubMed
12.
go back to reference Fisher DG, Reynolds GL, Ware MR, Napper LE. Methamphetamine and Viagra use: Relationship to sexual risk behaviors. Arch Sex Behav. 2009; epub Mar 28 2009. Fisher DG, Reynolds GL, Ware MR, Napper LE. Methamphetamine and Viagra use: Relationship to sexual risk behaviors. Arch Sex Behav. 2009; epub Mar 28 2009.
13.
go back to reference Purcell DW, Wolitski RJ, Hoff CC, Parsons JT, Woods WJ, Halkitis PN. Predictors of the use of viagra, testosterone, and antidepressants among HIV-seropositive gay and bisexual men. AIDS. 2005;19(Suppl 1):S57–66.CrossRefPubMed Purcell DW, Wolitski RJ, Hoff CC, Parsons JT, Woods WJ, Halkitis PN. Predictors of the use of viagra, testosterone, and antidepressants among HIV-seropositive gay and bisexual men. AIDS. 2005;19(Suppl 1):S57–66.CrossRefPubMed
14.
go back to reference Cooperman NA, Arnsten JH, Klein RS. Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev. 2007;19(4):321–33.CrossRefPubMed Cooperman NA, Arnsten JH, Klein RS. Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev. 2007;19(4):321–33.CrossRefPubMed
15.
go back to reference Cachay E, Mar-Tang M, Mathews WC. Screening for potentially transmitting sexual risk behaviors, urethral sexually transmitted infection, and sildenafil use among males entering care for HIV infection. AIDS Patient Care Stds. 2004;18(6):349–54.CrossRefPubMed Cachay E, Mar-Tang M, Mathews WC. Screening for potentially transmitting sexual risk behaviors, urethral sexually transmitted infection, and sildenafil use among males entering care for HIV infection. AIDS Patient Care Stds. 2004;18(6):349–54.CrossRefPubMed
16.
go back to reference Ostrow DG, Plankey MW, Cox C, et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr. 2009;51(3):349–55.CrossRefPubMed Ostrow DG, Plankey MW, Cox C, et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr. 2009;51(3):349–55.CrossRefPubMed
17.
go back to reference Hulgan T. Klausner JD: Phosphodiesterase type-5 inhibitors and the reemerging HIV epidemic. JAMA. 2008;299(12):1426.CrossRefPubMed Hulgan T. Klausner JD: Phosphodiesterase type-5 inhibitors and the reemerging HIV epidemic. JAMA. 2008;299(12):1426.CrossRefPubMed
19.
go back to reference Justice AC, Dombrowski E, Conigliaro J, et al. Veterans Aging Cohort Study (VACS): Overview and description. Med Care. 2006;44(8 Suppl 2):S13–24.CrossRefPubMed Justice AC, Dombrowski E, Conigliaro J, et al. Veterans Aging Cohort Study (VACS): Overview and description. Med Care. 2006;44(8 Suppl 2):S13–24.CrossRefPubMed
20.
go back to reference Babor T, Ramon Dela Fuente J, Saunders J, Grant M. The alcohol use dsorders identification test: guidelines for use in primary health care. Geneva: World Health Organization; 1989. Babor T, Ramon Dela Fuente J, Saunders J, Grant M. The alcohol use dsorders identification test: guidelines for use in primary health care. Geneva: World Health Organization; 1989.
21.
go back to reference Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRefPubMed Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRefPubMed
22.
go back to reference Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.CrossRefPubMed Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.CrossRefPubMed
23.
go back to reference Royston P. Multiple imputation of missing values: further update of ice, with an emphasis on interval censoring. Stata Journal. 2007;7:445–64. Royston P. Multiple imputation of missing values: further update of ice, with an emphasis on interval censoring. Stata Journal. 2007;7:445–64.
24.
go back to reference van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med. 1999;18(6):681–94.CrossRefPubMed van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med. 1999;18(6):681–94.CrossRefPubMed
25.
go back to reference Drumright LN, Gorbach PM, Little SJ, Strathdee SA. Associations between substance use, erectile dysfunction medication and recent HIV infection among men who have sex with men. AIDS Behav. 2009;13(2):328–36.CrossRefPubMed Drumright LN, Gorbach PM, Little SJ, Strathdee SA. Associations between substance use, erectile dysfunction medication and recent HIV infection among men who have sex with men. AIDS Behav. 2009;13(2):328–36.CrossRefPubMed
26.
go back to reference Fisher DG, Malow R, Rosenberg R, Reynolds GL, Farrell N, Jaffe A. Recreational Viagra use and sexual risk among drug abusing men. Am J Infect Dis. 2006;2(2):107–14.CrossRefPubMed Fisher DG, Malow R, Rosenberg R, Reynolds GL, Farrell N, Jaffe A. Recreational Viagra use and sexual risk among drug abusing men. Am J Infect Dis. 2006;2(2):107–14.CrossRefPubMed
27.
go back to reference Hackett G. The burden and extent of comorbid conditions in patients with erectile dysfunction. Int J Clin Pract. 2009;63(8):1205–13.CrossRefPubMed Hackett G. The burden and extent of comorbid conditions in patients with erectile dysfunction. Int J Clin Pract. 2009;63(8):1205–13.CrossRefPubMed
28.
go back to reference Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol. 2009;29(2):157–64.CrossRefPubMed Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol. 2009;29(2):157–64.CrossRefPubMed
29.
go back to reference Crum-Cianflone NF, Bavaro M, Hale B, et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS. 2007;21(1):9–19.CrossRefPubMed Crum-Cianflone NF, Bavaro M, Hale B, et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS. 2007;21(1):9–19.CrossRefPubMed
30.
go back to reference Cook RL, McGinnis KA, Kraemer KL, et al. Intoxication before intercourse and risky sexual behavior in male veterans with and without human immunodeficiency virus infection. Med Care. 2006;44(8 Suppl 2):S31–6.CrossRefPubMed Cook RL, McGinnis KA, Kraemer KL, et al. Intoxication before intercourse and risky sexual behavior in male veterans with and without human immunodeficiency virus infection. Med Care. 2006;44(8 Suppl 2):S31–6.CrossRefPubMed
Metadata
Title
Erectile Dysfunction Drug Receipt, Risky Sexual Behavior and Sexually Transmitted Diseases in HIV-infected and HIV-uninfected Men
Authors
Robert L. Cook, MD, MPH
Kathleen A. McGinnis, MS
Jeffrey H. Samet, MD
David A. Fiellin, MD
Maria C. Rodriquez-Barradas, MD
Kevin L. Kraemer, MD, MSc
Cynthia L. Gibert, MD, MSc
R. Scott Braithwaite, MD, MSc, FACP
Joseph L. Goulet, PhD, MS
Kristin Mattocks, PhD, MPH
Stephen Crystal, PhD
Adam J. Gordon, MD, MPH
Krisann K. Oursler, MD, ScM
Amy C. Justice, MD, PhD
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 2/2010
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-1164-9

Other articles of this Issue 2/2010

Journal of General Internal Medicine 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine